L 745870

Drug Profile

L 745870

Latest Information Update: 14 Aug 1998

Price : $50

At a glance

  • Originator Merck & Co
  • Class
  • Mechanism of Action Dopamine D4 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Schizophrenia

Most Recent Events

  • 14 Aug 1998 Discontinued-II for Schizophrenia in USA (Unknown route)
  • 13 Jan 1998 A preclinical study has been added to the pharmacodynamics section
  • 28 Aug 1997 A study has been added to the therapeutic trials section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top